Reactions 1680, p168 - 2 Dec 2017 Headache and gastrointestinal symptoms: case report An adult woman [age at reaction onset not clearly stated] developed headache and gastrointestinal symptoms during therapy with immune globulin [IVIg; route and dosage not stated]. The woman, at the age of 46 years, was diagnosed with generalised myasthenia gravis. She received pyridostigmine and prednisolone therapy. However, there was no improvement. Then, she had undergone thymectomy and plasma exchange. Following the thymectomy, her generalised weakness and bulbar symptoms were exacerbated. Hence, she was administered with immune globulin, followed by plasma exchange therapy. Her symptoms then improved. However, after 3–4 months, her generalised weakness worsened again. She was then prescribed with plasma exchange and 3–4 courses of immune globulin for every year. However, due to the immune globulin therapy, she developed headache and gastrointestinal symptoms [time to reactions onsets and outcomes not stated]. Author comment: "She was prescribed [plasma exchange] and 3–4 courses of [immune globulin] every year, but was unable to tolerate the medication because of headache or gastrointestinal symptoms." Muto K, et al. Memory B cell resurgence requires repeated rituximab in myasthenia gravis. Neuromuscular Disorders 27: 918-922, No. 10, Oct 2017. Available from: URL: http://doi.org/10.1016/j.nmd.2017.06.012 - Japan 803284364 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera